" class="no-js "lang="en-US"> Element Biosciences - Medtech Alert
Friday, March 29, 2024
Element Biosciences | Pharmtech Focus

Element Biosciences

About Element Biosciences

Element Biosciences

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high-quality data, increase workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improving the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation, and biochemistry to drastically decrease run costs and capital costs while delivering high sequencing data quality.

Related Story

Element Biosciences Welcomes Former ThermoFisher Executive Shelly Peariso to their Growing Commercial Team

September 2 2022

Element Biosciences, Inc.— developer of the AVITI™ System, a new and disruptive DNA sequencing platform — […]

seqWell and Element Biosciences Partner to Demonstrate Sequencing Performance of Multiplexed plexWell Technology With the AVITI System

June 1 2022

seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, today […]